Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

PURPOSE: A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pathan, Ansar A., Minassian, Angela M., Sander, Clare R., Rowland, Rosalind, Porter, David W., Poulton, Ian D., Hill, Adrian V.S., Fletcher, Helen A., McShane, Helen
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424417/
https://ncbi.nlm.nih.gov/pubmed/22789508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.06.084
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares